Kamada (KMDA) Operating Income (2012 - 2026)
Kamada (KMDA) posted quarterly Operating Income of $7.0 million for Q1 2026, down 10.8% year-on-year from $7.8 million in Q1 2025, and down 17.55% on a QoQ basis from $8.4 million in Q4 2025.
Kamada (KMDA) Operating Income (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Operating Income for 15 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Income fell 10.8% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 billion (up 57564.72% YoY) and the FY2025 annual result came in at $26.2 million, up 30.83% from the prior year.
- Operating Income slipped to $7.0 million in Q1 2026 per KMDA's latest filing, from $8.4 million in the prior quarter.
- Over the last five years, Operating Income for KMDA reached as high as $18.9 billion in Q2 2025 and fell as low as -$2.3 million in Q2 2022.
- A 5-year average of $1.5 billion and a median of $7.8 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 319.31% — and 2025, when it surged 335520.44%.
- Year by year, Operating Income stood at $4.0 million in 2022, then tumbled by 30.91% to $2.8 million in 2023, then jumped by 247.41% to $9.6 million in 2024, then slipped by 12.56% to $8.4 million in 2025, then fell by 17.55% to $7.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $7.0 million, $8.4 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 6.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.95 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 12.32 Mn |
| Jun 30, 2025 | 18.93 Bn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 9.64 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 2.78 Mn |
| Sep 30, 2023 | 4.37 Bn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 289.00 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 2.56 Bn |
| Jun 30, 2022 | -2.29 Mn |
| Mar 31, 2022 | 246,000.00 |
| Dec 31, 2021 | -3.30 Mn |
| Sep 30, 2021 | -804,000.00 |
| Jun 30, 2021 | 1.05 Mn |